BIRC5 and osteosarcoma: In osteosarcoma, NR2F1-AS1 enhances cell motility through miR-483-3p/FOXA1 and miR-485-5p/miR-218-5p/BIRC5 pathways, contributing to ECM degradation and metastasis [42, 43].